News for CureVac N.V. (CVACN.MX)

CureVac among global top 100 most fast-paced innovators for third consecutive year in acknowledgment of its innovative strength and extensive intellectual prope

CureVac N.V. (NASDAQ:CVAC) Q3 2024 Earnings Conference Call November 12, 2024 9:00 AM ETCompany ParticipantsSarah Fakih - Vice President of Corporate...

CureVac Announces Financial Results for the Third Quarter and First Nine Months of 2024 and Provides Business Update

CureVac to Report Third Quarter and First Nine Months 2024 Financial Results and Business Update on November 12, 2024

CureVac to Present at the Society for Immunotherapy of Cancer (SITC) 39th Annual Meeting

With over 80 key companies active in the RNA therapies space, the market is projected to grow due to advancements in mRNA, siRNA, and antisense...

CureVac N.V. recently secured a significant deal with GSK, boosting its cash reserves. Learn more about CVAC stock and the impact of this deal.

GSK advances mRNA flu vaccine after positive Phase 2 data

Moderna, Inc.'s combination flu and COVID-19 vaccine, mRNA-1083, showed strong Phase 3 results in adults over 50. Click here to ready my MRNA update.

CureVac appoints new director to enhance R&D

London-based VivoPower International PLC (VVPR) is up over 121 percent in Wednesday's pre-market trading. The following are some of the other stocks making big moves in Wednesday's pre-market trading.

Loading... Loading... Shares of XP Inc. XP fell sharply during Wednesday's session after the company reported worse-than-expected first-quarter EPS results. X...

The global Vaccine Adjuvants market size is expected to reach USD 2.90 billion by 2030 and exhibit a CAGR of 11.9% in the forecast period (2023−2030),...

The growth of the market for Neoantigen cancer vaccines is primarily attributable to rapid technological advancements and improvements in the healthcare...

Newark, New Castle, USA, June 30, 2023 (GLOBE NEWSWIRE) -- In accordance with the recent Growth Plus Reports study, the Global mRNA Therapeutics Market...

The RNA interference therapy pipeline and clinical trial analysis report deliver important insights on ongoing research, clinical strategies, upcoming...

/PRNewswire/ -- mRNA Vaccines Market Overview: As per the latest published Cognitive Market Research analysis, the mRNA Vaccines market size is projected to...

/PRNewswire/ -- The "Global mRNA Therapeutics Market Size, Share & Trends Analysis Report by Application (Infectious Diseases, Oncology), by Type (Prophylactic...

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Ju...